| Scrip code | 540719 |
|---|---|
| NSE Symbol | SBILIFE |
| MSEI Symbol | NOTLISTED |
| ISIN | INE123W01016 |
| Name of Company | SBI LIFE INSURANCE COMPANY LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Type Of Insurance | Non-Linked Policy And Linked Policy |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 24-07-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 10-07-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | First quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Start date and time of board meeting | 24-07-2026 11:00:00 |
| End date and time of board meeting | 24-07-2026 14:35:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| The Company doesn't have any borrowings hence the disclosure with respect to defualt on loans and borrowing is not applicable | |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Policyholders' Accounts | |||
| 1 | Income | ||
| (i) | Gross premium income | ||
| (a) | First Year Premium | 4,95,493.41 | 4,95,493.41 |
| (b) | Renewal Premium | 12,38,178.64 | 12,38,178.64 |
| (c) | Single Premium | 3,95,293.47 | 3,95,293.47 |
| Gross premium income | 21,28,965.52 | 21,28,965.52 | |
| (ii) | Net premium income | 20,07,820.91 | 20,07,820.91 |
| (iii) | Income from investments (Net) | 25,97,702.11 | 25,97,702.11 |
| (iv) | Other income | ||
| 1 | Unclaim Investment Income | 37.61 | 37.61 |
| 2 | Bank Charges recovery | 2.92 | 2.92 |
| 3 | Interest on renewal Premium | 6.81 | 6.81 |
| 4 | Interest on revived policies | 994.86 | 994.86 |
| 5 | Stale Cheque written back | 0.99 | 0.99 |
| 6 | FMC Income on Variable insurance products (VIP) | 0.00 | 0.00 |
| 7 | Other Income | 2,503.34 | 2,503.34 |
| Total other income | 3,546.53 | 3,546.53 | |
| (v) | Transfer Of Funds From Shareholders Account | 0.00 | 0.00 |
| (vi) | Total Income | 46,09,069.55 | 46,09,069.55 |
| 2 | Expenses | ||
| (i) | Commission on | ||
| (a) | First Year Premium | 61,236.04 | 61,236.04 |
| (b) | Renewal Premium | 25,150.75 | 25,150.75 |
| (c) | Single Premium | 6,569.17 | 6,569.17 |
| Total Commission | 92,955.96 | 92,955.96 | |
| (ii) | Net Commission | 92,955.96 | 92,955.96 |
| (iii) | Operating Expenses related to insurance business | ||
| (a) | Employees remuneration and welfare expenses | 79,862.54 | 79,862.54 |
| (b) | Administration expenses | 0.00 | 0.00 |
| (c) | Advertisement and publicity | 5,434.68 | 5,434.68 |
| (b) | Other operating expenses | ||
| 1 | Legal & professional charges | 7,489.53 | 7,489.53 |
| 2 | Depreciation | 3,466.16 | 3,466.16 |
| 3 | Rent, rates & taxes | 3,888.83 | 3,888.83 |
| 4 | Information technology expenses | 6,735.60 | 6,735.60 |
| 5 | Stamp duty on policies | 15,346.89 | 15,346.89 |
| 6 | Travel, conveyance and vehicle running expenses | 3,618.30 | 3,618.30 |
| 7 | Repairs | 172.88 | 172.88 |
| 8 | Communication expenses | 2,112.61 | 2,112.61 |
| 9 | Training Expenses | 745.41 | 745.41 |
| 10 | Other expenses | 34,672.15 | 34,672.15 |
| Total other operating expenses | 78,248.36 | 78,248.36 | |
| Total operating expenses related to insurance business | 1,63,545.58 | 1,63,545.58 | |
| Total Expenses of Management | 2,56,501.54 | 2,56,501.54 | |
| (iv) | Provisions for doubtful debts (including bad debts written off) | 9.52 | 9.52 |
| (v) | Provisions for diminution in value of investments | (26.39) | (26.39) |
| (vi) | Goods & Service tax charge on linked charges | 39.64 | 39.64 |
| (vii) | Provision for taxes | ||
| Current Tax | 4,725.47 | 4,725.47 | |
| Deffered Tax | 0.00 | 0.00 | |
| Total provision of taxes | 4,725.47 | 4,725.47 | |
| (viii) | Benefits Paid (Net) | 13,12,672.43 | 13,12,672.43 |
| (ix) | Change in actuarial liability | 29,81,156.30 | 29,81,156.30 |
| Total Expenses | 45,55,078.51 | 45,55,078.51 | |
| 3 | Net Surplus(Deficit) | 53,991.04 | 53,991.04 |
| 4 | Appropriations | ||
|---|---|---|---|
| (a) | Transferred to Shareholders A/c | 45,778.44 | 45,778.44 |
| (b) | Funds for Future Appropriation | 8,212.60 | 8,212.60 |
| 5 | Details of Surplus / Deficit | ||
| (a) | Interim bonus paid | 675.43 | 675.43 |
| (b) | Allocation of bonus to policyholders | 0.00 | 0.00 |
| (c) | Surplus shown in the Revenue Account | 53,991.04 | 53,991.04 |
| (d) | Terminal bonus paid | 12,757.24 | 12,757.24 |
| Total Surplus (Deficit ) | 67,423.71 | 67,423.71 | |
| 1 | Income | ||
|---|---|---|---|
| (i) | Transfer from Poliycholders' Account | 45,778.44 | 45,778.44 |
| (ii) | Income under Shareholders' Account | ||
| (a) | Investment Income | 28,155.00 | 28,155.00 |
| (b) | Other income | ||
| 1 | Profit/(Loss )on sale of Fixed Asset | 19.20 | 19.20 |
| Total Other income | 19.20 | 19.20 | |
| Total income under shareholders account | 28,174.20 | 28,174.20 | |
| Total Income | 73,952.64 | 73,952.64 | |
| 2 | Expenses | ||
| (i) | Expenses other than those related to insurance business | 694.40 | 694.40 |
| (ii) | Transfer of funds to policyholders account | 0.00 | 0.00 |
| (iii) | Provisions for doubtful debts (including write off) | 0.00 | 0.00 |
| (iv) | Provisions for diminution in value of investments | (1,329.22) | (1,329.22) |
| Total Expenses | (634.82) | (634.82) | |
| 3 | Profit/ (loss) before tax | 74,587.46 | 74,587.46 |
| 4 | Provisions for tax | 2,094.15 | 2,094.15 |
| (i) | Current tax | 2,094.15 | 2,094.15 |
| (ii) | Deffered tax | 0.00 | 0.00 |
| 5 | Profit / (loss) after tax and before Extraordinary Items | 72,493.31 | 72,493.31 |
| 6 | Extraordinary Items (Net of tax expenses) | 0.00 | 0.00 |
| 7 | Profit/ (loss) after tax and Extraordinary Items | 72,493.31 | 72,493.31 |
| 8 | Dividend per share | ||
| (a) | Interim Dividend | 0.00 | 0.00 |
| (b) | Final Dividend | 0.00 | 0.00 |
| 9 | Profit/(Loss) carried to Balance Sheet | 18,55,499.22 | 18,55,499.22 |
| 10 | Paid up equity share capital | 1,00,324.05 | 1,00,324.05 |
| 11 | Reserve & Surplus (excluding Revaluation Reserve) | 18,82,201.24 | 18,82,201.24 |
| 12 | Fair Value Change Account and Revaluation Reserve (Shareholders) | 29,401.02 | 29,401.02 |
| 13 | Assets | ||
| (i) | Investments: | ||
| (a) | Shareholders | 18,47,758.69 | 18,47,758.69 |
| (b) | Policyholders Fund excluding Linked Assets | 2,22,19,738.48 | 2,22,19,738.48 |
| (c) | Assets held to cover Linked Liabilities | 2,83,47,941.89 | 2,83,47,941.89 |
| Total Investments | 5,24,15,439.06 | 5,24,15,439.06 | |
| (b) | Other Assets (Net of current liabilities and provisions) | 1,89,168.57 | 1,89,168.57 |
| Total Assets | 5,26,04,607.63 | 5,26,04,607.63 | |
| 14 | Analytical Ratios | ||
| (i) | Solvency Ratio | 196.00 | 196.00 |
| (ii) | Expenses of Management Ratio | 12.0500 | 12.0500 |
| (iii) | Policyholder 's liabilities to shareholders' fund | 2,514.41 | 2,514.41 |
| (iv) | Earnings per share (Rs.): | ||
| (a) | Basic and diluted EPS before extraordinary items (net of tax expense) for the period (not to be annualized) | 7.23 | 7.23 |
| (b) | Basic and diluted EPS after extraordinary items (net of tax expense) for the period (not to be annualized) | 7.22 | 7.22 |
| (v) | NPA ratios: (for policyholders' fund) | ||
| (a) | Gross NPAs | ||
| Non Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Net NPAs | |||
| Non Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| % of Gross NPAs | |||
| Non Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| % of Net NPAs | |||
| Non Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| (vi) | Yield on Investments (on policyholders' fund) | ||
| (a) | Without unrealised gains | ||
| Non Linked | |||
| Par | 7.1900 | 7.1900 | |
| Non Par | 7.200 | 7.200 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 5.4800 | 5.4800 | |
| (b) | With unrealised gains | ||
| Non Linked | |||
| Par | 23.3500 | 23.3500 | |
| Non Par | 21.1600 | 21.1600 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 34.0700 | 34.0700 | |
| (vii) | NPA ratios: (for shareholders' fund) | ||
| (a) | Gross NPAs | 0.00 | 0.00 |
| Net NPAs | 0.00 | 0.00 | |
| (b) | Percentage of Gross NPAs | 0 | 0 |
| Percentage of Net NPAs | 0 | 0 | |
| (viii) | Yield on Investments (on shareholders' fund) | ||
| (a) | Without unrealised gains | 6.74 | 6.74 |
| (b) | With unrealised gains | 22.22 | 22.22 |
| (ix) | Persistency Ratio | ||
| 1 | 13th Month | 84.3500 | 84.3500 |
| 2 | 25th Month | 76.7500 | 76.7500 |
| 3 | 37th Month | 70.9100 | 70.9100 |
| 4 | 49th Month | 67.900 | 67.900 |
| 5 | 61st Month | 59.100 | 59.100 |
| (ix) | Other Rations | ||
| (x) | Conservation Ratio | 87.900 | 87.900 |
| (xi) | Percentage of shares held by Government of India (in case of public sector insurance companies) | 0 | 0 |
| Investor Compliants | |||
|---|---|---|---|
| (i) | No of investor complaints pending at the beginning of the period | 0 | 0 |
| (ii) | No of investor complaints during the period | 7 | 7 |
| (iii) | No of investor complaints disposed off during the period | 7 | 7 |
| (iv) | No of investor complaints remaining unresolved at the end of the period | 0 | 0 |
| (c) | Notes Format for financial results by life insurance companies filed with stock exchanges |
|---|---|
| 1. The Company doesn't have any subsidiary/associate/joint venture companies requiring consolidation under AS-21; therefore consolidated financial statements are not applicable to the Company. 2. The above financial results for the quarter ended June 30, 2026 have been reviewed by the Board Audit Committee and approved by the Board of Directors at its meeting held on July 23, 2026 and July 24, 2026 respectively. 3. The financial results have been prepared in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended and IRDA circular IRDA/F&I/REG/CIR/208/10/2016 dated October 25, 2016 on publication of financial results for life insurance companies. 4. The above financial results have been reviewed by the Joint Statutory Auditors, M/s. K S Aiyar & Co, Chartered Accountants and M/s J Singh & Associates, Chartered Accountants. 5. In view of seasonality of the industry, the financial results for the quarter or interim period are not necessarily indicative of the results that may be expected of any other interim period or full year. 6. During the quarter ended June 30, 2026 the Company has allotted 148,413 equity shares with face value of Rs.10 each to its eligible employees pursuant to exercise of employee stock options in accordance with the Company's Employee Stock Option Scheme 2018 (ESOS 2018). 7. Insurance Regulatory and Development Authority of India (‘IRDAI’) vide its order dated June 2, 2023 (‘IRDAI order’) passed in terms of section 52B (2) of the Insurance Act, 1938 has directed to transfer the life insurance business of Sahara India Life Insurance Company Limited (‘SILIC’) involving policy liabilities and policyholders’ investment/ assets to SBI Life Insurance Company Limited (‘SBI Life’ or ‘the Company’). On appeal filed by SILIC against the said IRDAI order, the Securities Appellate Tribunal ('SAT' or 'Tribunal') vide its order dated June 13, 2023 has granted stay on the effect and operation of the said IRDAI order. Subsequently, the IRDAI has filed an appeal with Hon’ble Supreme Court against the stay order passed by SAT. The Hon’ble Supreme Court in its hearing held on July 17, 2023 has set aside Securities Appellate Tribunal’s (SAT) stay and directed the SAT to hear the case and decide it afresh. Thereafter, the SAT, vide its order dated December 5, 2025, has dismissed the appeal filed by SILIC and upheld the order passed by the IRDAI dated June 2, 2023 therefore the order is no longer sub judice. The Company had sought necessary directions from IRDAI for compliance with the IRDAI Order dated June 2, 2023. As per the Authority’s directions, the Company shall continue to maintain separate books of account for SILIC during FY 2026-27. Accordingly, the closing balance of SILIC portfolio as at March 31, 2027 and transactions from April 1, 2027, pertaining to SILIC’s Policyholder’s shall be reflected in the Company’s financial statements. 8. IRDAI has issued the IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026 (“Amended Regulations”), mandating that all insurance companies prepare their financial statements in accordance with the applicable Indian Accounting Standards (Ind AS) with effect from April 1, 2026. The Amended Regulations also provide insurers the option to seek a one year forbearance, subject to prior approval of IRDAI, for deferring the implementation of Ind AS. In accordance with the above regulatory provisions and the Board approved Ind AS transition plan, the Company submitted an application to IRDAI seeking a one year forbearance. IRDAI has granted the forbearance for FY 2026-27, permitting the Company to defer the adoption of Ind AS by one year. Accordingly, these financial results of the Company are prepared in accordance with Indian GAAP (accounting principles generally accepted in India). 9. In accordance with requirement of IRDAI Master Circular on 'Presentation of Financial Statements and Filing of Returns' and IRDAI circular no. IRDAI/F&A/CIR/MISC/256/09/2021 dated September 30, 2021, the Company will publish the financials on the Company's website latest by August 14, 2026. 10. Analytical ratios have been calculated as per definition given in IRDAI Analytical ratios disclosures. 11. Basic and diluted EPS is not annualized for three months. 12. The persistency ratios are calculated as per IRDAI circular IRDAI/NL/MSTCIR/RT/93/6/2024 dated June 14, 2024. i) Persistency ratios for the three months ended June 30, 2026 are for the quarter persistency calculated using policies issued in 1st March to 31st May of the relevant years. 13. Net Premium is Net of reinsurance 14. Income from investments is net of amortisation and Losses (including capital gains) 15. Profit and Loss carried forward to balance sheet represents accumulated profit. 16.Net Commission includes rewards. 17. The figures of quarter ended March 31, 2026 as reported in these financial results are the balancing figures between audited figures in respect of full financial year and published year-to-date figures upto the end of the third quarter of the relevant financial year. 18. Figures of the previous period/year have been regrouped/ reclassified/restated wherever necessary, in order to make them comparable. | |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Income | |||
| 1 | Name of segment | Participating Life | |
| (i) | Net premium | 1,34,742.98 | 1,34,742.98 |
| (ii) | Income form investments | 1,07,080.42 | 1,07,080.42 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 336.36 | 336.36 |
| 2 | Name of segment | Participating Pension | |
| (i) | Net premium | 4,100.74 | 4,100.74 |
| (ii) | Income form investments | 6,491.42 | 6,491.42 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 9.25 | 9.25 |
| 3 | Name of segment | Participating VIP | |
| (i) | Net premium | 167.64 | 167.64 |
| (ii) | Income form investments | 968.14 | 968.14 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | (0.09) | (0.09) |
| 4 | Name of segment | Non Participating Life | |
| (i) | Net premium | 3,97,208.18 | 3,97,208.18 |
| (ii) | Income form investments | 1,39,566.36 | 1,39,566.36 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 3,123.11 | 3,123.11 |
| 5 | Name of segment | Non Participating Pension | |
| (i) | Net premium | 101.89 | 101.89 |
| (ii) | Income form investments | 583.72 | 583.72 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.07 | 0.07 |
| 6 | Name of segment | Non Participating Group Life | |
| (i) | Net premium | 3,51,522.38 | 3,51,522.38 |
| (ii) | Income form investments | 79,212.64 | 79,212.64 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 5.36 | 5.36 |
| 7 | Name of segment | Non Participating Annuity | |
| (i) | Net premium | 1,48,583.34 | 1,48,583.34 |
| (ii) | Income form investments | 59,440.01 | 59,440.01 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 9.66 | 9.66 |
| 8 | Name of segment | Non Participating Health | |
| (i) | Net premium | 285.81 | 285.81 |
| (ii) | Income form investments | 500.43 | 500.43 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.56 | 0.56 |
| 9 | Name of segment | Non Participating VIP | |
| (i) | Net premium | 216.45 | 216.45 |
| (ii) | Income form investments | 2,566.55 | 2,566.55 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.25 | 0.25 |
| 10 | Name of segment | Linked Individual Life | |
| (i) | Net premium | 7,75,229.98 | 7,75,229.98 |
| (ii) | Income form investments | 18,46,969.77 | 18,46,969.77 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 245.23 | 245.23 |
| 11 | Name of segment | Linked Group | |
| (i) | Net premium | 24,586.00 | 24,586.00 |
| (ii) | Income form investments | 9,017.78 | 9,017.78 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | (0.34) | (0.34) |
| 12 | Name of segment | Linked Pension | |
| (i) | Net premium | 1,71,075.52 | 1,71,075.52 |
| (ii) | Income form investments | 3,45,331.26 | 3,45,331.26 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | (183.18) | (183.18) |
| 13 | Name of segment | Shareholders | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 29,484.43 | 29,484.43 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 19.20 | 19.20 |
| 14 | Name of segment | Unallocated | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Surplus/(Deficit) (net of transfer from shareholders' A/c) | |||
| 1 | Participating Life | 6,863.46 | 6,863.46 |
| 2 | Participating Pension | 1,101.72 | 1,101.72 |
| 3 | Participating VIP | 851.16 | 851.16 |
| 4 | Non Participating Life | (21,401.16) | (21,401.16) |
| 5 | Non Participating Pension | 299.36 | 299.36 |
| 6 | Non Participating Group Life | 25,593.23 | 25,593.23 |
| 7 | Non Participating Annuity | 318.75 | 318.75 |
| 8 | Non Participating Health | 516.85 | 516.85 |
| 9 | Non Participating VIP | 1,119.15 | 1,119.15 |
| 10 | Linked Individual Life | 21,320.79 | 21,320.79 |
| 11 | Linked Group | (162.11) | (162.11) |
| 12 | Linked Pension | 17,569.63 | 17,569.63 |
| 13 | Shareholders | 26,714.88 | 26,714.88 |
| 14 | Unallocated | 0.00 | 0.00 |
| Notes Segment Surplus/(Deficit) | |
|---|---|
| Textual Information | 1. Segments include: a. Linked Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable b. Non-Linked 1. Non-Participating Policies: (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable 2. Participating Policies : (i) Life (ii) General Annuity and Pension (iii) Health (iv) Variable c. Variable insurance further segregated into Life, General Annuity and Pension and Health where any such segment contributes ten per cent or more of the total premium of the Company. 2. Net of Provisions for diminution in value of investments and provision for standard and non-standard assets. 3. Segment policy liabilities includes fund for future appropriation and Credit/(debit) fair value change account on policyholders fund. |
| Partiuclars | Current Quarter | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-06-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | |
| Segment Assets | ||
| 1 | Participating Life | 62,72,452.09 |
| 2 | Participating Pension | 3,55,333.54 |
| 3 | Participating VIP | 34,502.53 |
| 4 | Non Participating Life | 73,50,842.94 |
| 5 | Non Participating Pension | 26,557.65 |
| 6 | Non Participating Group Life | 44,66,882.54 |
| 7 | Non Participating Annuity | 34,54,603.40 |
| 8 | Non Participating Health | 14,497.25 |
| 9 | Non Participating VIP | 93,759.29 |
| 10 | Linked Individual Life | 2,17,53,899.47 |
| 11 | Linked Group | 2,01,141.18 |
| 12 | Linked Pension | 65,82,673.20 |
| 13 | Shareholders | 20,12,098.41 |
| 14 | Unallocated | (14,636.07) |
| Partiuclars | Current Quarter | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | ||
| Date of end of reporting period | 30-06-2026 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Segment Liabilities | |||
| 1 | Participating Life | 62,68,658.06 | |
| 2 | Participating Pension | 3,51,687.23 | |
| 3 | Participating VIP | 34,122.52 | |
| 4 | Non Participating Life | 73,57,685.05 | |
| 5 | Non Participating Pension | 25,661.77 | |
| 6 | Non Participating Group Life | 44,63,762.18 | |
| 7 | Non Participating Annuity | 34,53,847.43 | |
| 8 | Non Participating Health | 14,198.00 | |
| 9 | Non Participating VIP | 89,282.76 | |
| 10 | Linked Individual Life | 2,17,49,972.06 | |
| 11 | Linked Group | 2,01,373.40 | |
| 12 | Linked Pension | 65,82,258.55 | |
| 13 | Shareholders | 20,12,098.41 | |
| 14 | Unallocated | 0.00 | |
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | M/s K S Aiyar & Co | Yes | 31-05-2028 | ||
|---|---|---|---|---|---|
| 2 | M/s J Singh & Associates | Yes | 31-12-2028 | ||